| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +75.00% | -1.68% | +0.34% | -2.02% | -0.81% | — |
| 14d | 4 | +75.00% | -1.33% | -0.49% | -0.84% | -0.12% | — |
| 30d | 4 | +50.00% | +8.81% | +1.85% | +6.96% | +5.13% | — |
| 60d | 4 | +75.00% | +9.28% | +7.00% | +2.28% | +1.43% | — |
| 90d | 4 | +75.00% | +4.99% | +7.37% | -2.38% | -5.74% | — |
| 180d | 4(2 pending) | +50.00% | +16.34% | +1.22% | +15.11% | +15.11% | — |
| 1y | 4(2 pending) | +50.00% | +32.92% | +12.73% | +20.19% | +20.19% | — |
| 2y | 4(2 pending) | +50.00% | +38.92% | +31.46% | +7.46% | +7.46% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| XENE XENON PHARMACEUTICALS INC. | SALE10b5-1 10b5-1 plan | 1,410 | $55.23 | $77.9K | 7,069 | Mar 13, 2026 | Mar 13, 2026 ↗ | View → |
| XENE XENON PHARMACEUTICALS INC. | SALE Chief Medical Officer | 3,750 | — | — | 11,250 | Mar 12, 2026 | Mar 13, 2026 ↗ | View → |
| XENE XENON PHARMACEUTICALS INC. | PURCHASE Chief Medical Officer | 3,750 | — | — | 8,479 | Mar 12, 2026 | Mar 13, 2026 ↗ | View → |
| XENE XENON PHARMACEUTICALS INC. | SALE10b5-1 10b5-1 plan | 2,771 | $60.11 | $166.6K | 4,729 | Mar 10, 2026 | Mar 11, 2026 ↗ | View → |
| XENE XENON PHARMACEUTICALS INC. | PURCHASE Chief Medical Officer | 7,500 | — | — | 7,500 | Mar 9, 2026 | Mar 11, 2026 ↗ | View → |
| XENE XENON PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 7,500 | — | — | 7,500 | Mar 9, 2026 | Mar 11, 2026 ↗ | View → |
| XENE XENON PHARMACEUTICALS INC. | SALE Chief Medical Officer | 7,500 | — | — | 0 | Mar 9, 2026 | Mar 11, 2026 ↗ | View → |
| XENE XENON PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Jan 9, 2026 | Jan 9, 2026 ↗ | View → |
| XENE XENON PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 20,000 | — | — | 20,000 | Jan 9, 2026 | Jan 9, 2026 ↗ | View → |
| XENE XENON PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 80,000 | — | — | 80,000 | Mar 12, 2025 | Mar 13, 2025 ↗ | View → |
| XENE XENON PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 15,000 | — | — | 15,000 | Mar 12, 2025 | Mar 13, 2025 ↗ | View → |
| XENE XENON PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Mar 11, 2024 | Mar 12, 2024 ↗ | View → |
| XENE XENON PHARMACEUTICALS INC. | SALE Chief Medical Officer | 700 | $35.01 | $24.5K | 0 | Mar 24, 2023 | Mar 24, 2023 ↗ | View → |
| XENE XENON PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 120,000 | — | — | 120,000 | Mar 10, 2023 | Mar 14, 2023 ↗ | View → |
| XENE XENON PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 125,000 | — | — | 125,000 | Mar 10, 2022 | Mar 14, 2022 ↗ | View → |
| XENE XENON PHARMACEUTICALS INC. | PURCHASE Chief Medical Officer | 700 | $28.81 | $20.2K | 700 | Jan 21, 2022 | Jan 21, 2022 ↗ | View → |
| XENE XENON PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 150,000 | Aug 23, 2021 | Aug 25, 2021 ↗ | View → |